<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
---------------
SCHEDULE 13D
(RULE 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
(AMENDMENT NO. )(1)
----
Sanguine Corporation
--------------------------------------------------------------------------------
(Name of Issuer)
Common Voting Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
801006 10 7
--------------------------------------------------------------------------------
(CUSIP Number)
Leonard W. Burningham, Suite 205, 455 East 500 South, Salt Lake City, UT 84111
(801) 363-7411
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 8, 2000
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [ ].
NOTE: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See
Rule 13d-7(b) for other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 5 Pages)
---------------
(1) The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
CUSIP NO. 801006 10 7 13D PAGE 2 OF 5 PAGES
--------------------- -------- --------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Westbury Consultancy Services, Ltd.
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ x ]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ]
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
---------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
---------------------------------------------------------------------
(7) SOLE VOTING POWER
Right to acquire 12,000,000 common shares upon
NUMBER OF exercise of warrants
SHARES --------------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER
OWNED BY -0-
EACH --------------------------------------------------------
REPORTING (9) SOLE DISPOSITIVE POWER
PERSON WITH Right to acquire 12,000,000 common shares upon
exercise of warrants
--------------------------------------------------------
(10) SHARED DISPOSITIVE POWER
-0-
--------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Right to acquire 12,000,000 common shares upon exercise of warrants
---------------------------------------------------------------------
(12) CHECK BOX IF AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
No shares are excluded in the numerical or percentage computations
herein.
---------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
49%
---------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
CO
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 3
Page 3 of 5 Pages
--- ---
Item 1. Security and Issuer.
Sanguine Corporation, a Nevada Corporation (SEC File No. 0-24480)
(the "Company")); 101 East Green Street, #11, Pasadena, California
91105; $0.001 par value common voting stock.
Item 2. Identity and Background.
(a) The name of the person filing this Schedule is
Westbury Consultancy Services, Ltd.
(b) The business address of
P.O. Box 362, Road Town, Tortola, British Virgin
Islands
(c) investment entity
(d) no
(e) no
(f) British Virgin Islands
Item 3. Source and Amount of Funds or Other Consideration.
Working capital of company. $3,000,000 total upon exercise of all
warrants
Item 4. Purpose of Transaction.
investment purposes
<PAGE> 4
Page 4 of 5 Pages
--- ---
Item 5. Interest in Securities of the Issuer.
(a) right to acquire 12,000,000 common shares upon exercise
of warrants
(b) right to acquire 12,000,000 common shares upon exercise
of warrants
(c) none
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or
Relationship With respect to Securities of the Issuer.
none
Item 7. Materials to be Filed as Exhibits.
none
<PAGE> 5
Page 5 of 5 Pages
--- ---
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, the undersigned certifies that the information set forth in the
Statement is true, correct and complete.
DATED: October 23, 2000
By: /s/ Natalie Dodo
------------------------------
Natalie Dodo, Director
Westbury Consultancy
Services, Ltd.
